ARCHIVES

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

Levine Leaves Presidency Of Rockefeller University.

February 15, 2002

In Brief: ASTRO Elects New Officers; ASSIST Coordinators Express Concern Over NCI Plan To Cut Budget

November 27, 1992

SBRT Delivers Higher Overall Survival Rates Compared to Conventional Radiation Therapy

November 30, 2012

NCI Ponders Options for Implementing NCAB Changes In Organ Site Program

June 4, 1982

Also In sudden policy change, NIH proposes one-year ban on consulting by employees.

October 1, 2004

Rauscher Says He May Leave, But Will Stay Through June

February 6, 1976